Upadacitinib: An Evolving Treatment for Ulcerative Colitis
The inhibition of Janus kinase to prevent downstream signaling of proinflammatory cytokines has been shown to be a novel method of treating ulcerative colitis.
Risankizumab: A New Treatment Option for Crohn’s Disease
Risankizumab represents the first ever IL-23 treatment for adult patients with Crohn's disease approved by the FDA.
Extraintestinal Manifestations of Inflammatory Bowel Disease: A Step Toward Standardizing Assessment
Investigators from the Cleveland Clinic standardized diagnostic, follow-up, and treatment targets for 5 major EIMs: peripheral arthritis, axial arthritis, pyoderma gangrenosum, erythema nodosum, and uveitis.
Fatty Pancreas: Is It a Benign Entity?
Investigators assessed the etiology, clinical implications, and long-term outcomes of fatty pancreas.
Introducing The Qazi Corner With Taha Qazi, MD
Here's what you have to look forward to from our new quarterly gastroenterology newsletter.
2 Clarke Drive Cranbury, NJ 08512